We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $11.1M

43% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 51

8% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 50

3% less funds holding

Funds holding: 200 → 195 (-5)

15.73% less ownership

Funds ownership: 132.15% → 116.42% (-16%)

33% less capital invested

Capital invested by funds: $2.27B → $1.51B (-$755M)

73% less funds holding in top 10

Funds holding in top 10: 11 → 3 (-8)

Holders
195
Holders Change
-5
Holders Change %
-2.5%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-72.73%
% of All Funds
0.04%
New
46
Increased
73
Reduced
51
Closed
50
Calls
$41.3M
Puts
$11.1M
Net Calls
+$30.2M
Net Calls Change
+$16.9M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
State Street
State Street
Massachusetts
+$45.7M
3
SL
Siren LLC
Connecticut
+$32.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$25.6M
5
DFO
Duquesne Family Office
New York
+$22M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$28M
2
VPC
Vestal Point Capital
New York
-$27.2M
3
SC
Samlyn Capital
New York
-$26.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$23M
5
EAM
Eventide Asset Management
Massachusetts
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
201
Silverarc Capital Management
Massachusetts
– -$5.16M -206,280 Closed
PA
202
Perceptive Advisors
New York
– -$4.14M -165,713 Closed
ECM
203
ExodusPoint Capital Management
New York
– -$3.77M -150,670 Closed
SSA
204
Schonfeld Strategic Advisors
New York
– -$2.85M -113,978 Closed
BHCM
205
Brevan Howard Capital Management
Jersey
– -$2.7M -107,950 Closed
SFI
206
Susquehanna Fundamental Investments
Pennsylvania
– -$2.37M -94,883 Closed
ACM
207
ADAR1 Capital Management
Texas
– -$2.03M -81,399 Closed
SCM
208
Soleus Capital Management
Connecticut
– -$1.75M -69,874 Closed
SG Americas Securities
209
SG Americas Securities
New York
– -$1.74M -69,382 Closed
HIS
210
Harvest Investment Services
Illinois
– -$1.72M -68,723 Closed
NIP
211
Nicholas Investment Partners
California
– -$1.62M -64,757 Closed
FAM
212
Fred Alger Management
New York
– -$1.61M -64,484 Closed
NIM
213
NEOS Investment Management
Connecticut
– -$1.13M -45,170 Closed
HF
214
HRT Financial
New York
– -$1.01M -40,266 Closed
CCIA
215
Campbell & Co Investment Adviser
Maryland
– -$889K -35,556 Closed
Verition Fund Management
216
Verition Fund Management
Connecticut
– -$835K -33,382 Closed
JG
217
Jain Global
New York
– -$754K -30,160 Closed
II
218
Ishara Investments
California
– -$750K -30,000 Closed
Renaissance Technologies
219
Renaissance Technologies
New York
– -$627K -25,067 Closed
EFMC
220
Empire Financial Management Company
New York
– -$625K -25,000 Closed
SC
221
Shay Capital
New York
– -$525K -21,000 Closed
HA
222
Huntleigh Advisors
Missouri
– -$503K -20,130 Closed
SRL
223
Scientech Research LLC
New Jersey
– -$437K -17,474 Closed
Polen Capital Management
224
Polen Capital Management
Florida
– -$380K -15,206 Closed
LCM
225
Legato Capital Management
California
– -$289K -11,554 Closed
6 7 8
9
10

OLMA Hedge Fund Activity: Q1 2026 in Review

195 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2026, worth a combined $1.51B — down 33% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OLMA and 46 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 73 added.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Franklin Resources, cutting an estimated $28M.

  • 195 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2026, down from 200 in Q4 2025.
  • Funds reported $1.51B of Olema Pharmaceuticals stock for Q1 2026, down 33% quarter-over-quarter.
  • 46 funds opened new Olema Pharmaceuticals positions in Q1 2026 and 50 closed out, a net change of -4 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $119M added.
  • The largest Olema Pharmaceuticals seller in Q1 2026 was Franklin Resources, an estimated $28M sold.

Based on aggregated 13F filings for Q1 2026.